Investigating 5-Level EQ-5D (EQ-5D-5L) Values Based on Preferences of Patients With Heart Disease

被引:6
|
作者
Gandhi, Mihir [1 ,2 ,3 ]
San Tan, Ru [4 ]
Lim, Shir Lynn [5 ]
Rand, Kim [6 ,7 ]
Lam, Carolyn S. P. [4 ]
Luo, Nan [8 ]
Cheung, Yin Bun [2 ,3 ]
机构
[1] Singapore Clin Res Inst, Biostat, 06-01,23 Rochester Pk, Singapore 139234, Singapore
[2] Duke NUS Med Sch, Ctr Quantitat Med, Singapore, Singapore
[3] Tampere Univ, Ctr Child Hlth Res, Tampere, Finland
[4] Natl Heart Ctr Singapore, Dept Cardiol, Singapore, Singapore
[5] Natl Univ Heart Ctr, Dept Cardiol, Singapore, Singapore
[6] Akershus Univ Hosp, Hlth Serv Res Ctr, Lorenskog, Norway
[7] Maths Hlth BV, Rotterdam, Netherlands
[8] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore
关键词
cardiovascular disease; EQ-5D; EQ-5D-5L; heart disease; patient preference; preference; utility; value set; OF-LIFE QUESTIONNAIRE; VALUE SET; HEALTH; VALUATION; QLU-C10D; ASIANS;
D O I
10.1016/j.jval.2021.09.010
中图分类号
F [经济];
学科分类号
02 ;
摘要
Objectives: Several studies have shown that patients with heart disease value hypothetical health states differently from the general population. We aimed to investigate the health preferences of patients with heart disease and develop a value set for the 5-level EQ-5D (EQ-5D-5L) based on these patient preferences.Methods: Patients with confirmed heart disease were recruited from 2 hospitals in Singapore. A total of 86 EQ-5D-5L health states (10 per patient) were valued using a composite time trade-off method according to the international valuation protocol for EQ-5D-5L; 20-parameter linear models and 8-parameter cross-attribute level effects models with and without an N45 term (indicating whether any health state dimension at level 4 or 5 existed) were estimated. Each model included patient-specific random intercepts. Model performance was evaluated for out-of-sample and in-sample predictive accuracy in terms of root mean square error. The discriminative ability of the utility values was assessed using heart disease-related functional classes.Results: A total of 576 patients were included in the analysis. The preferred model, with the lowest out-of-sample root mean square error, was a 20-parameter linear model including N45. Predicted utility values ranged from 20.727 for the worst state to 1 for full health; the value for the second-best state was 0.981. Utility values demonstrated good discriminative ability in differentiating among patients of varied functional classes.Conclusions: An EQ-5D-5L value set representing the preferences of patients with heart disease was developed. The value set could be used for patient-centric economic evaluation and health-related quality of life assessment for patients with heart disease.
引用
收藏
页码:451 / 460
页数:10
相关论文
共 50 条
  • [41] A French Value Set for the EQ-5D-5L
    Andrade, Luiz Flavio
    Ludwig, Kristina
    Ramos Goni, Juan Manuel
    Oppe, Mark
    de Pouvourville, Gerard
    PHARMACOECONOMICS, 2020, 38 (04) : 413 - 425
  • [42] EQ-5D-5L Value Set for Slovenia
    Rupel, Valentina Prevolnik
    Ogorevc, Marko
    PHARMACOECONOMICS, 2023, 41 (11) : 1515 - 1524
  • [43] The EQ-5D-5L valuation study in Korea
    Kim, Seon-Ha
    Ahn, Jeonghoon
    Ock, Minsu
    Shin, Sangjin
    Park, Jooyeon
    Luo, Nan
    Jo, Min-Woo
    QUALITY OF LIFE RESEARCH, 2016, 25 (07) : 1845 - 1852
  • [44] Parallel Valuation of the EQ-5D-3L and EQ-5D-5L by Time Trade-Off in Hungary
    Rencz, Fanni
    Brodszky, Valentin
    Gulacsi, Laszlo
    Golicki, Dominik
    Ruzsa, Gabor
    Pickard, A. Simon
    Law, Ernest H.
    Pentek, Marta
    VALUE IN HEALTH, 2020, 23 (09) : 1235 - 1245
  • [45] EQ-5D-5L versus EQ-5D-3L: The Impact on Cost Effectiveness in the United Kingdom.
    Alava, Monica Hernandez
    Wailoo, Allan
    Grimm, Sabine
    Pudney, Stephen
    Gomes, Manuel
    Sadique, Zia
    Meads, David
    O'Dwyer, John
    Barton, Garry
    Irvine, Lisa
    VALUE IN HEALTH, 2018, 21 (01) : 49 - 56
  • [46] German Value Set for the EQ-5D-5L
    Ludwig, Kristina
    von der Schulenburg, J. -Matthias Graf
    Greiner, Wolfgang
    PHARMACOECONOMICS, 2018, 36 (06) : 663 - 674
  • [47] EQ-5D-5L is More Responsive than EQ-5D-3L to Treatment Benefit of Cataract Surgery
    Gandhi, Mihir
    Ang, Marcus
    Teo, Kelvin
    Wong, Chee Wai
    Wei, Yvonne Chung-Hsi
    Tan, Rachel Lee-Yin
    Janssen, Mathieu F.
    Luo, Nan
    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2019, 12 (04) : 383 - 392
  • [48] How the EQ-5D utilities are derived matters in Chinese diabetes patients: a comparison based on different EQ-5D scoring functions for China
    Pan, Chen-Wei
    Zhang, Ruo-Yu
    Luo, Nan
    He, Jun-Yi
    Liu, Rui-Jie
    Ying, Xiao-Hua
    Wang, Pei
    QUALITY OF LIFE RESEARCH, 2020, 29 (11) : 3087 - 3094
  • [49] EQ-5D-5L measurement properties are superior to EQ-5D-3L across the continuum of health using US value sets
    Jiang, Ruixuan
    Rand, Kim
    Kuharic, Maja
    Pickard, A. Simon
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2022, 20 (01)
  • [50] A Value Set for EQ-5D-5L in the United Arab Emirates
    Al Sayah, Fatima
    Roudijk, Bram
    El Sadig, Mohamed
    Al Mannaei, Asma
    Farghaly, Mohamad N.
    Dallal, Sara
    Kaddoura, Rima
    Metni, Mirna
    Elbarazi, Iffat
    Kharroubi, Samer A.
    VALUE IN HEALTH, 2025, 28 (04) : 611 - 621